Intermediate
Vetsi Pharma is adherent to high quality product development process.
This is achieved through constant modernization and meeting regulatory standards.
This is achieved through constant modernization and meeting regulatory standards.
The company is involved in the manufacturing and
development of wide range of high quality pharmaceutical
advance intermediates in its modern state of art facilities.
Vetsi Pharma is adherent to high quality product development
process. This is achieved through constant modernization and
meeting regulatory standards. The company is managed by dynamic
and highly technically qualified partners and professionals who
have a sound and vast experience in manufacturing of Pharmaceutical Intermediates
| Sr. No. | Intermediate | CAS No. | Name of API | Status |
|---|---|---|---|---|
| 1 | Dibenzo-(b,f)(1,4)thiazepine-11(10H)-one | [3159-07-7] | Quetiapine fumarate | Commercial |
| 2 | 1-(2-(2-Hydroxyethoxy)ethyl)piperazine | [13349-82-1] | Quetiapine fumarate | Under development |
| 3 | 7-Hydroxy-2-quinolinone | [70500-72-0] | Brexpiprazole | Under development |
| 4 | 2-(4-chlorobenzoyl)benzoic acid | [85-56-3] | Chlorthalidone | Commercial |
| 5 | 5-(2-methoxy phenoxy)-(2,2bipyrimidine)-4,6-(1H,5H)-dione | [150728-12-4] | Bosentan | Under development |
| 6 | 4,6-Dichloro-5-(2-methoxyphenoxy)-2,2-bipyrimidine | [150728-13-5] | Bosentan | Commercial |
| 7 | 2-(phenoxymethyl)benzoic acid | [724-98-1] | Doxepin hydrochloride | Commercial |
| 8 | Dibenzo(b,e)oxepin-11(6H)-one | [4504-87-4] | Doxepin hydrochloride | Commercial |
| 9 | 4-Hydroxy-thiobenzamide | [25984-63-8] | Febuxostat | Commercial |
| 10 | 2-(4-Hydroxy-phenyl)-4-methyl-thiazole-5-carboxalic acid ethyl ester | [161797-99-5] | Febuxostat | Commercial |
| 11 | 3-(1-piperazinyl)-1,2-benzisothiazole | [87691-87-0] | Lurasidone Hydrochloride | Under development |
| 12 | (1R,2R)-1,2 bis(methane sulfonyl-oxymethyl)cyclohexane | [186204-35-3] | Lurasidone Hydrochloride | Under development |
| 13 | Bicyclo(2,2,1)hep-tane-2,3-exodicarboximide | [14805-29-9] | Lurasidone Hydrochloride | Under development |
| 14 | 6-Fluoro-3,4-dihyro-2H-1-benzopyran-2-carboxylic acud | [99199-60-7 | Nebivolol hydrochloride | Under development |
| 15 | (1s*(R*))-6-fluoro-3,4-dihydroxy-2-oxiranyl-2H-1-benzopyran | [793669-26-8] | Nebivolol hydrochloride | Commercial |
| 16 | (1S*(S*))-6-fluoro-3,4-dihydroxy-2-oxiranyl-2H-1-benzopyran | [876514-31-7] | Nebivolol hydrochloride | Commercial |
| 17 | (1S*(R*))-6-fluoro-3,4-dihydroxy((phenylmethyl)amino)methyl)2H-1-benzopyran-2-methanol | [99199-91-4] | Nebivolol hydrochloride | Commercial |
| 18 | (S)-2(benzyl(R)-2(S)-6-fluorochroman-2yl)-2-hydroxyethyl)amino-1-(R)-6-fluorochroman-2-)
ethan-1-olHydrochloride |
[876666-09-0] | Nebivolol hydrochloride | Commercial |
| 19 | (S)-1-phenyl-1,2,3,4-tertahydroisoquinoline | [118864-75-8]] | Solefenacin Succinate | Under development |
| 20 | 6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one | [118289-55-7] | iprasidone hydrochloride | Under development |
| 21 | 3-(1-Piperazinyl)-1,2-benzisothiazole hydrochloride | [87691-88-1] | Ziprasidone hydrochloride | Under development |
REGISTERED
Office Address
Vetsi Pharma LLP
C 120 – Jay Yogeshwar Complex,Kudasan
Gandhinagar – 382421
C 120 – Jay Yogeshwar Complex,Kudasan
Gandhinagar – 382421
